Tag Archives: Medical Marijuana

Cannabis: how it affects our cognition and psychology – new research

Cannabis has been used by humans for thousands of years and is one of the most popular drugs today. With effects such as feelings of joy and relaxation, it is also legal to prescribe or take in several countries.

But how does using the drug affect the mind? In three recent studies, published in The Journal of Psychopharmacology, Neuropsychopharmacology and the International Journal of Neuropsychopharmacology, we show that it can influence a number of cognitive and psychological processes.

The United Nations Office on Drugs and Crime reported that, in 2018, approximately 192 million people worldwide aged between 15 and 64 used cannabis recreationally. Young adults are particularly keen, with 35% of people between the ages of 18 and 25 using it, while only 10% of people over the age of 26 do.

This indicates that the main users are adolescents and young adults, whose brains are still in development. They may therefore be particularly vulnerable to the effects of cannabis use on the brain in the longer term.

Tetrahydrocannabinol (THC) is the main psychoactive compound in cannabis. It acts on the brain’s “endocannabinoid system”, which are receptors which respond to the chemical components of cannabis. The cannabis receptors are densely populated in prefrontal and limbic areas in the brain, which are involved in reward and motivation. They regulate signalling of the brain chemicals dopamine, gamma-aminobutyric acid (GABA) and glutamate.

We know that dopamine is involved in motivation, reward and learning. GABA and glutamate play a part in cognitive processes, including learning and memory.

Cognitive effects

Cannabis use can affect cognition, especially in those with cannabis-use disorder. This is characterised by the persistent desire to use the drug and disruption to daily activities, such as work or education. It has been estimated that approximately 10% of cannabis users meet the diagnostic criteria for this disorder.

In our research, we tested the cognition of 39 people with the disorder (asked to be clean on the day of testing), and compared it with that of 20 people who never or rarely used cannabis. We showed that participants with the condition had significantly worse performance on memory tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB) compared to the controls, who had either never or very rarely used cannabis. It also negatively affected their “executive functions”, which are mental processes including flexible thinking.

This effect seemed to be linked to the age at which people started taking the drug – the younger they were, the more impaired their executive functioning was.

Cognitive impairments have been noted in mild cannabis users as well. Such users tend to make riskier decisions than others and have more problems with planning.

Although most studies have been conducted in males, there has been evidence of sex differences in the effects of cannabis use on cognition. We showed that, while male cannabis users had poorer memory for visually recognising things, female users had more problems with attention and executive functions. These sex effects persisted when controlling for age; IQ; alcohol and nicotine use; mood and anxiety symptoms; emotional stability; and impulsive behaviour.

Reward, motivation and mental health

Cannabis use can also affect how we feel – thereby further influencing our thinking. For example, some previous research has suggested that reward and motivation – along with the brain circuits involved in these processes – can be disrupted when we use cannabis. This may affect our performance at school or work as it can make us feel less motivated to work hard, and less rewarded when we do well.

In our recent study, we used a brain imaging task, in which participants were placed in a scanner and viewed orange or blue squares. The orange squares would lead to a monetary reward, after a delay, if the participant made a response. This set up helped us investigate how the brain responds to rewards.

We focused particularly on the ventral striatum, which is a key region in the brain’s reward system. We found that the effects on the reward system in the brain were subtle, with no direct effects of cannabis in the ventral striatum. However, the participants in our study were moderate cannabis users. The effects may be more pronounced in cannabis users with more severe and chronic use, as seen in cannabis use disorder.

There is also evidence that cannabis can lead to mental health problems. We have shown that it is related to higher “anhedonia” – an inability to feel pleasure – in adolescents. Interestingly, this effect was particularly pronounced during the COVID-19 pandemic lockdowns.

Cannabis use during adolescence has also been reported as a risk factor for developing psychotic experiences as well as schizophrenia. One study showed that cannabis use moderately increases the risk of psychotic symptoms in young people, but that it has a much stronger effect in those with a predisposition for psychosis (scoring highly on a symptom checklist of paranoid ideas and psychoticism).

Assessing 2,437 adolescents and young adults (14-24 years), the authors reported a six percentage points increased risk – from 15% to 21% – of psychotic symptoms in cannabis users without a predisposition for psychosis. But there was a 26-point increase in risk – from 25% to 51% – of psychotic symptoms in cannabis users with a predisposition for psychosis.

We don’t really know why cannabis is linked to psychotic episodes, but hypotheses suggests dopamine and glutamate may be important in the neurobiology of these conditions.

Another study of 780 teenagers suggested that the association between cannabis use and psychotic experiences was also linked to a brain region called the “uncus”. This lies within the parahippocampus (involved in memory) and olfactory bulb (involved in processing smells), and has a large amount of cannabinoid receptors. It has also previously been associated with schizophrenia and psychotic experiences.

Cognitive and psychological effects of cannabis use are ultimately likely to depend to some extent on dosage (frequency, duration and strength), sex, genetic vulnerabilities and age of onset. But we need to determine whether these effects are temporary or permanent. One article summarising many studies has suggested that with mild cannabis use, the effects may weaken after periods of abstinence.

But even if that’s the case, it is clearly worth considering the effects that prolonged cannabis use can have on our minds – particularly for young people whose brains are still developing.

Barbara Jacquelyn Sahakian, Professor of Clinical Neuropsychology, University of Cambridge; Christelle Langley, Postdoctoral Research Associate, Cognitive Neuroscience, University of Cambridge; Martine Skumlien, PhD Candidate in Psychiatry, University of Cambridge, and Tianye Jia, Professor of Population Neuroscience, Fudan University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Related Articles:


Check out Lynxotic on YouTube

Find books on Music, Movies & Entertainment and many other topics at Bookshop.org

Lynxotic may receive a small commission based on any purchases made by following links from this page

CBD: How To Find A Way Though The Growing Maze of Products and Treatments

Photo / Adobe Stock

The desire towards more natural and homeopathic alternatives vs. traditional medicines is a current and growing trend.  

Interest in CBD in particular has increased after Congress passed The Farm Bill, making some cannabis plants legal (with restrictions). This growing demand in the, now legal, use of hemp and marijuana products is bringing many newcomers, tempted to try it out. At the same time, many are not quite sure what CBD is and how it is different from THC or Medical Marijuana.

More popularly known, THC is what most people associate with the active ingredient in Cannabis sativa plant a.k.a. hemp, when smoking marijuana comes to mind.  Other street or informal names linked to THC use include: weed, grass, pot, ganga and reefer.  Cannabidiol (CBD), an additional active ingredient in Cannabis, on the other hand, has had much less attention amongst the lay person or even recreational users up until recently. 

Read More: Sustainable Energy is Now Essential to Rescue Economy and Planet: Earth Day 2020

Let’s Talk Science

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) are two well-known chemical compounds referred to as cannabinoids.  Both compounds are found within the cannabis plant and looking at their molecular makeup they appear almost exactly the same which could lead to the assumption they also act similarly. However, the compounds are very different and have opposite bodily effects to the user.

Our body has cannabinoid receptors called CB1 and CB2 that are found within our endocannabinoid system (ECS).  The distinct difference that sets CBD apart from THC is that only THC binds with the CB1 receptor; the part of the brain responsible for mental and cognitive processes (memory, concentration, and coordination), thus resulting in the “high” or “stoned” feeling. 

Since CBD does not bind to these receptors there is a lack of any psychoactive or mind-altering effects and instead interacts with other receptors that affect pain perception, body temperature and inflammation. People using CBD have reported feeling relaxed, a sense of calm, a relief from body pains or feeling a “body high” compared to the “head/brain high” from THC.

The Green Medicine

CBD has been associated with providing benefits, in some people, for a wide range of ailments from the moderate like anxiety, insomnia, inflammation, depression, tension, headaches, and chronic pain; to the more severe – diabetes, Alzheimer’s, cancer, as well as neurological disorders.

Medical professionals have started implementing the drug into their practice, more and more. In a survey conducted by Chiropractic Economics (EC), doctors across the United States have reported 26% of clinics and offices now use and sell CBD products. 

Even large chain pharmacies like CVS, for example, have recently announced they will begin to sell CBD products at 800 of their stores in Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee. 

There has been an increase in clinical research to explore the medical benefits and uses for the drug. In June 2018, the U. S Food and Drug Administration (FDA) recognized and approved Epidolex, as the first cannabis derived CBD pharmaceutical to be used as a form of medical treatment for a rare pediatric seizure disorder.

The Many Ways to Use

There are many different CBD products on the market nowadays, and the ways in which to consume them are both creative and ever growing. There are oils, vaporizers (vapes), dabs/waxes, capsules, edibles, topical skin creams and ointments, and even treats geared for pets.

Figuring out the right dosage is unique and must be individually determined as there are many factors that influence the outcome (e.g. body weight, stress levels, overall health, diet and sleep, ect). 

To further complicate matters, in deciding what is the right dose to best start with, most product strains usually include both THC and CBD. To recap THC gets you “high” and CBD does not.

It is very rare to find the two chemical compounds completely isolated in any given product, and therefore it is important to note how they vary in ratio (or percentage); the higher the ratio of THC the higher the level of psychoactive effects and vice versa. 

Project CBD recommends to start slow and with a low dosage when beginning treatment, in order to test out how the chemicals interact with your body, and determining what dosage reaches the desired effects.

Read More: “Wuhan Diary” reveals inside accounts of Coronavirus Lockdown During the Peak

Warnings and Other Red Flags

Due to the growing demand, there has been a rapid increase in CBD products that are largely going out to the public unregulated. The FDA has expressed concerns over the growing number of products and companies that market the therapeutic benefits without proper approval.

An upcoming public hearing (May 31, 2019) could potentially result in stricter regulations on CBD dosage contained within food and drink products. 

The FDA continues to be concerned about the proliferation of egregious medical claims being made about products asserting to contain CBD that haven’t been approved by the FDA.”

Statement from FDA Commissioner Scott Gottlieb, M.D

Some users have reported the following side effects: changes in appetite and mood, diarrhea, anxiety, dizziness, drowsiness, nausea, dry mouth, and vomiting. 

In addition, because CBD is relatively new to consumers, there is not enough data currently, nor longitudinal studies conducted over an extended period of years, to properly support or confirm the drug’s efficacy, safety, and long term results on the body.

Future research is necessary, however in the meantime with the CBD craze in full effect, it is recommended – if you are looking to try it out: do your own due diligence, as well as research into local laws, to ensure the drug is legal where you live.


Find books on Big TechSustainable EnergyEconomics and many other topics at our sister site: Cherrybooks on Bookshop.org

Enjoy Lynxotic at Apple News on your iPhone, iPad or Mac and subscribe to our newsletter.

Lynxotic may receive a small commission based on any purchases made by following links from this page.